COHERUS BIOSCIENCES INC (CHRS)

US19249H1032 - Common Stock

2.02  -0.16 (-7.34%)

Premarket: 2.07 +0.05 (+2.48%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to CHRS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.64. This target is 426.59% above the current price.
CHRS was analyzed by 16 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CHRS.
In the previous month the buy percentage consensus was at a similar level.
CHRS was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 2.024.049.1810.6424.15 - 100.00% 354.46% 426.59% 1,095.54%
Up and Down Grades
Date Firm Action Rating
2024-03-20 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-01-23 Truist Securities Maintains Buy -> Buy
2024-01-23 Baird Maintains Outperform -> Outperform
2023-12-27 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-28 Truist Securities Reiterate Buy -> Buy
2023-11-17 Baird Initiate Outperform
2023-11-08 Maxim Group Downgrade Buy -> Hold
2023-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-23 Barclays Maintains Overweight -> Overweight
2023-09-26 Truist Securities Reiterate Buy -> Buy
2023-09-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-03 HC Wainwright & Co. Maintains Buy -> Buy
2023-07-24 Citigroup Initiate Buy
2023-07-14 Truist Securities Maintains Buy -> Buy
2023-06-28 Truist Securities Reiterate Buy -> Buy
2023-06-20 Truist Securities Maintains Buy -> Buy
2023-06-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-15 Truist Securities Reiterate Buy -> Buy
2023-06-06 HC Wainwright & Co. Reiterate Buy
2023-06-01 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-23 Barclays Maintains Overweight -> Overweight
2023-05-09 HC Wainwright & Co. Maintains Buy
2023-05-01 Truist Securities Initiate Buy
2023-03-28 UBS Upgrade Neutral -> Buy
2023-03-08 Barclays Maintains Overweight
2023-03-07 HC Wainwright & Co. Maintains Buy
2022-11-16 Mizuho Maintains Buy
2022-11-14 JP Morgan Maintains Neutral